CLINICAL_TRIALS
trial_result
· 2020-10-12
Clinical Trial Update: Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer [Phase 2]
Summary
Phase 2 trial evaluating enzalutamide in combination with hormone therapy before, during, and after radiation in high-risk localized prostate cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-10-12